Cardiol Therapeutics

(NASDAQ) CRDL

Current Price$1.12

Market Cap$124.18M

Since IPO (2019)-69%

5 Year-59%

1 Year-20%

1 Month-16%

Cardiol Therapeutics Financials at a Glance

Market Cap

$124.18M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$36.38M

EPS (TTM)

-$0.28

P/E Ratio

-3.93

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$1.12

Volume

19,142

Open

$1.12

Price

$1.12

Volume

19,142

Open

$1.12

Previous Close

$1.12

Daily Range

$1.10 - $1.15

52-Week Range

$0.88 - $1.71

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$1.12

Volume

19,142

Open

$1.12

Previous Close

$1.12

Daily Range

$1.10 - $1.15

52-Week Range

$0.88 - $1.71

Estimated Earnings Date

Aug 13, 2026

CRDL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiol Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

David G. Elsley, MBA

Website

www.cardiolrx.com

Headquarters

Oakville, ON L6H 0G5, CA

CRDL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-178%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-25.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$124.18M

Shares Outstanding

111.87M

Volume

19.14K

Avg. Volume

689.49K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$34.32M

EBITDA

-CA$34.21M

Operating Cash Flow

-CA$23.85M

Capital Expenditure

-CA$24.48K

Free Cash Flow

-CA$23.88M

Cash & ST Invst.

CA$21.42M

Total Debt

CA$125.52K

Cardiol Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$26.78K

N/A

Gross Margin

0.00%

N/A

Market Cap

$124.18M

N/A

Market Cap/Employee

$6.90M

N/A

Employees

N/A

Net Income

-CA$10.85M

-30.9%

EBITDA

-CA$9.71M

-15.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

CA$27.63M

+19.4%

Accounts Receivable

CA$340.58K

-1.8%

Inventory

CA$0.00

N/A

Long Term Debt

CA$76.81K

-34.0%

Short Term Debt

CA$39.89K

+16.5%

Return on Assets

-1.16%

N/A

Return on Invested Capital

-1.47%

N/A

Free Cash Flow

-CA$7.58M

-5.8%

Operating Cash Flow

-CA$7.54M

-5.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HYPRHyperfine, Inc.

HYPRHyperfine, Inc.$1.38-8.00%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$1.84-8.00%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.17-5.65%

ASRTAssertio Holdings, Inc.

ASRTAssertio Holdings, Inc.$23.44-0.04%

MBOTMicrobot Medical Inc.

MBOTMicrobot Medical Inc.$1.84-6.12%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$4.44-4.72%

VANIVivani Medical, Inc.

VANIVivani Medical, Inc.$1.18-7.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

MRVLMarvell Technology

MRVLMarvell Technology$263.47-0.17%

Questions About CRDL

What is the current price of Cardiol Therapeutics?

Cardiol Therapeutics is trading at $1.12 per share.

What is the 52-week range for Cardiol Therapeutics?

Over the past 52 weeks, Cardiol Therapeutics has traded between $0.88 and $1.71.

How much debt does Cardiol Therapeutics have?

As of the most recent reporting period, Cardiol Therapeutics reported total debt of CA$83.41K.

How much cash does Cardiol Therapeutics have on hand?

Cardiol Therapeutics reported CA$19.83M in cash and cash equivalents in its most recent financial results.

What is Cardiol Therapeutics’s dividend yield?

Cardiol Therapeutics does not currently have a dividend yield.

Cardiol Therapeutics

Cardiol Therapeutics Financials at a Glance

CRDL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cardiol Therapeutics

CRDL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cardiol Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRDL

What is the current price of Cardiol Therapeutics?

What is the 52-week range for Cardiol Therapeutics?

How much debt does Cardiol Therapeutics have?

How much cash does Cardiol Therapeutics have on hand?

What is Cardiol Therapeutics’s dividend yield?

Premium Investing Services